Literature DB >> 24491408

MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression.

Kripa Patel1, Anita Kollory1, Asami Takashima1, Sibaji Sarkar1, Douglas V Faller1, Sajal K Ghosh2.   

Abstract

Although dispensable for normal pancreatic function, STAT3 signaling is frequently activated in pancreatic cancers. Consistent downregulation of expression of microRNA let-7 is also characteristic of pancreatic ductal adenocarcinoma (PDAC) biopsy specimens. We demonstrate in this study that re-expression of let-7 in poorly-differentiated PDAC cell lines reduced phosphorylation/activation of STAT3 and its downstream signaling events and reduced the growth and migration of PDAC cells. Let-7 re-expression did not repress expression of STAT3 protein or its activator cytokine interleukin 6 (IL-6). However, let-7 re-expression enhanced cytoplasmic expression of suppressor of cytokine signaling 3 (SOCS3), which blocks STAT3 activation by JAK2. Our study thus identified a mechanism by which STAT3 signaling can be inhibited in pancreatic cancer cells by modifying let-7 expression.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  EMT; Let-7; Pancreatic cancer; SOCS3; STAT3

Mesh:

Substances:

Year:  2014        PMID: 24491408      PMCID: PMC3972339          DOI: 10.1016/j.canlet.2014.01.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  68 in total

1.  Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents.

Authors:  Sajal K Ghosh; Susan P Perrine; Robert M Williams; Douglas V Faller
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

2.  Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.

Authors:  Yu Wang; Yiwei Lu; Soo Ting Toh; Wing-Kin Sung; Patrick Tan; Pierce Chow; Alexander Y F Chung; London L P Jooi; Caroline G L Lee
Journal:  J Hepatol       Date:  2010-04-02       Impact factor: 25.083

Review 3.  STATs: signal transducers and activators of transcription.

Authors:  J N Ihle
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

4.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Biol Pharm Bull       Date:  2006-05       Impact factor: 2.233

5.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

Review 6.  Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.

Authors:  Angela L McCleary-Wheeler; Gwen A Lomberk; Frank U Weiss; Günter Schneider; Muller Fabbri; Tara L Poshusta; Nelson J Dusetti; Sandra Baumgart; Juan L Iovanna; Volker Ellenrieder; Raul Urrutia; Martin E Fernandez-Zapico
Journal:  Cancer Lett       Date:  2012-10-13       Impact factor: 8.679

7.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

8.  miR-203 represses 'stemness' by repressing DeltaNp63.

Authors:  A M Lena; R Shalom-Feuerstein; P Rivetti di Val Cervo; D Aberdam; R A Knight; G Melino; E Candi
Journal:  Cell Death Differ       Date:  2008-05-16       Impact factor: 15.828

9.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

Authors:  Thiruvengadam Arumugam; Vijaya Ramachandran; Keith F Fournier; Huamin Wang; Lauren Marquis; James L Abbruzzese; Gary E Gallick; Craig D Logsdon; David J McConkey; Woonyoung Choi
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

Review 10.  Genetic alterations in pancreatic carcinoma.

Authors:  Gunter Schneider; Roland M Schmid
Journal:  Mol Cancer       Date:  2003-01-22       Impact factor: 27.401

View more
  32 in total

Review 1.  Noncoding RNAs and pancreatic cancer.

Authors:  Juan-Fei Peng; Yan-Yan Zhuang; Feng-Ting Huang; Shi-Neng Zhang
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

2.  C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

Authors:  Hang Li; Bo Zhang; Meng Ding; Shang Lu; Hui Zhou; Dajun Sun; Gang Wu; Xianfeng Gan
Journal:  Hepatol Int       Date:  2019-05-08       Impact factor: 6.047

3.  Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.

Authors:  An-Quan Shang; Jian Wu; Feng Bi; Yu-Jie Zhang; Lei-Rong Xu; Ling-Ling Li; Fei-Fei Chen; Wei-Wei Wang; Jian-Jun Zhu; You-Yi Liu
Journal:  Cancer Biol Ther       Date:  2017-04-27       Impact factor: 4.742

Review 4.  The age factor in axonal repair after spinal cord injury: A focus on neuron-intrinsic mechanisms.

Authors:  Cédric G Geoffroy; Jessica M Meves; Binhai Zheng
Journal:  Neurosci Lett       Date:  2016-11-03       Impact factor: 3.046

Review 5.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

6.  Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.

Authors:  Virender Kumar; Goutam Mondal; Paige Slavik; Satyanarayna Rachagani; Surinder K Batra; Ram I Mahato
Journal:  Mol Pharm       Date:  2015-02-25       Impact factor: 4.939

Review 7.  MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.

Authors:  Mehdi Sajjadi-Dokht; Talar Ahmad Merza Mohamad; Heshu Sulaiman Rahman; Marwah Suliman Maashi; Svetlana Danshina; Navid Shomali; Saeed Solali; Faroogh Marofi; Elham Zeinalzadeh; Morteza Akbari; Ali Adili; Ramin Aslaminabad; Majid Farshdousti Hagh; Mostafa Jarahian
Journal:  Genes Dis       Date:  2021-12-03

Review 8.  Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.

Authors:  Lisa N Heppler; David A Frank
Journal:  Trends Cancer       Date:  2017-11-10

Review 9.  Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.

Authors:  Yi-Ting Tang; Xiao-Hui Xu; Xiao-Dong Yang; Jun Hao; Han Cao; Wei Zhu; Shu-Yu Zhang; Jian-Ping Cao
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

10.  The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells.

Authors:  Luisa Klemke; Clara F Fehlau; Nadine Winkler; Felicia Toboll; Shiv K Singh; Ute M Moll; Ramona Schulz-Heddergott
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.